ArticleAnnals of translational medicine2022

Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter study.

Yan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.